Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 6/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | CCR5 | P51681 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25686648 | 0.85 | AKR1C3 (0.41) | AKR1C3AKR1C2LMNAKMT2AMEN1 | |
| SCHEMBL18653239 | 0.82 | LMNA (0.38) | LMNAHTTALDH1A1TP53 | |
| SCHEMBL30914 | 0.82 | AKR1C3 (0.37) | AKR1C3AKR1C2LMNAKMT2AMEN1 | |
| SCHEMBL8298727 | 0.81 | ALDH1A1 (0.46) | AKR1C3AKR1C2LMNAKMT2AMEN1 | |
| SCHEMBL20811478 | 0.81 | ALDH1A1 (0.46) | AKR1C3AKR1C2LMNAKMT2AMEN1 | |
| SCHEMBL25853238 | 0.80 | AKR1C3 (0.40) | AKR1C3AKR1C2LMNAKMT2AMEN1 | |
| SCHEMBL29890 | 0.80 | PSEN1 (0.37) | — | |
| SCHEMBL23891693 | 0.79 | TAS1R3 (0.32) | — | |
| SCHEMBL19493737 | 0.76 | CES2 (0.34) | — | |
| SCHEMBL8256534 | 0.76 | AKR1C3 (0.47) | AKR1C3AKR1C2LMNAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3889138-A1 | HISTONE ACETYLASE P300 INHIBITOR AND USE THEREOF | Hinova Pharmaceuticals Inc. (CN) | 2021-10-06 | — | — | EP | disclosed |